BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang K, Wang C, Jiang H, Zhang Y, Lin W, Mo J, Jin C. Combination of Ablation and Immunotherapy for Hepatocellular Carcinoma: Where We Are and Where to Go. Front Immunol 2021;12:792781. [PMID: 34975896 DOI: 10.3389/fimmu.2021.792781] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Sun F, Tong Y, Zhang C, Yang S, Liu Y, Ji J, Yu Z, Zhao Y. Lawsone inhibits the proliferation and metastasis of residual breast cancer cells after microwave ablation by inducing cellular inhibitory autophagy through NCAPG/AURKB/AKT/mTOR axis.. [DOI: 10.21203/rs.3.rs-2520455/v1] [Reference Citation Analysis]
2 Sarıyar E, Karpat O, Sezan S, Baylan SM, Kıpçak A, Guven K, Erdal E, Fırtına Karagonlar Z. EGFR and Lyn inhibition augments regorafenib induced cell death in sorafenib resistant 3D tumor spheroid model. Cell Signal 2023;105:110608. [PMID: 36693455 DOI: 10.1016/j.cellsig.2023.110608] [Reference Citation Analysis]
3 Ouranos K, Chatziioannou A, Goulis I, Sinakos E. Role of immunotherapy in downsizing hepatocellular carcinoma prior to liver transplantation. World J Transplant 2022; 12(11): 331-346 [DOI: 10.5500/wjt.v12.i11.331] [Reference Citation Analysis]
4 Rizzo A, Ricci AD, Brandi G. Trans-Arterial Chemoembolization Plus Systemic Treatments for Hepatocellular Carcinoma: An Update. J Pers Med 2022;12. [PMID: 36579504 DOI: 10.3390/jpm12111788] [Reference Citation Analysis]
5 Dai Q, Cao B, Zhao S, Zhang A. Synergetic Thermal Therapy for Cancer: State-of-the-Art and the Future. Bioengineering 2022;9:474. [DOI: 10.3390/bioengineering9090474] [Reference Citation Analysis]
6 Yin L, Li X, Zhu L, Chen G, Xiang Z, Wang Q, Bi J, Wang Q. Clinical application status and prospect of the combined anti-tumor strategy of ablation and immunotherapy. Front Immunol 2022;13:965120. [DOI: 10.3389/fimmu.2022.965120] [Reference Citation Analysis]
7 Wu Y, Cao F, Zhou D, Chen S, Qi H, Huang T, Tan H, Shen L, Fan W. Cryoablation reshapes the immune microenvironment in the distal tumor and enhances the anti-tumor immunity. Front Immunol 2022;13:930461. [DOI: 10.3389/fimmu.2022.930461] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Liu Q, Zhang W, Jiao R, Lv Z, Lin X, Xiao Y, Zhang K. Rational Nanomedicine Design Enhances Clinically Physical Treatment-Inspired or Combined Immunotherapy. Adv Sci (Weinh) 2022;:e2203921. [PMID: 36002305 DOI: 10.1002/advs.202203921] [Reference Citation Analysis]
9 De Re V, Rossetto A, Rosignoli A, Muraro E, Racanelli V, Tornesello ML, Zompicchiatti A, Uzzau A. Hepatocellular Carcinoma Intrinsic Cell Death Regulates Immune Response and Prognosis. Front Oncol 2022;12:897703. [DOI: 10.3389/fonc.2022.897703] [Reference Citation Analysis]
10 Tian Z, Hong B, Chen J, Tang Z. Combination of Radiofrequency Ablation With Resiquimod to Treat Hepatocellular Carcinoma Via Inflammation of Tumor Immune Microenvironment and Suppression of Angiogenesis. Front Oncol 2022;12:891724. [PMID: 35719978 DOI: 10.3389/fonc.2022.891724] [Reference Citation Analysis]